PFS | |||||
---|---|---|---|---|---|
Parameter | SE | HR | 95%CI | WAld’s p | |
Subgroup A(1st line, chemo-naïve) | |||||
Age | −0.028 | 0.011 | 0.973 | 0.952-0.994 | 0.012 |
TYMS | |||||
aberrant vs. normal | 0.577 | 0.253 | 1.780 | 1.084-2.923 | 0.563 |
Treatment | |||||
platinum vs. taxanes | 0.235 | 0.407 | 1.265 | 0.570-2.811 | 0.563 |
tax/plat vs. taxanes | −0.220 | 0.303 | 0.802 | 0.443-1.452 | 0.467 |
other vs. taxanes | 0.088 | 0.376 | 1.092 | 0.522-2.282 | 0.816 |
aberrant TYMS *platinum | −1,687 | 0.564 | 0.003 | ||
aberrant TYMS *tax/plat | −1.200 | 0.433 | 0.006 | ||
Subgroup B(1st line, chemo-naïve) | |||||
Age | −0.002 | 0.010 | 0.978 | 0.959-0.998 | 0.034 |
TYMS | |||||
aberrant vs. normal | 0.539 | 0.255 | 1.714 | 1.040-2.824 | 0.034 |
Treatment | |||||
platinum vs. taxanes | 0.293 | 0.382 | 1.340 | 0.0633-2.836 | 0.444 |
tax/plat vs. taxanes | −0.129 | 0.285 | 0.879 | 0.502-1.537 | 0.650 |
other vs. taxanes | −6.631 | 0.439 | 0.532 | 0.225-1.258 | 0.151 |
aberrant TYMS*platinum | −1.719 | 0.551 | 0.002 | ||
aberrant TYMS*tax/plat | −1.233 | 0.420 | 0.003 | ||
aberrant TYMS *other treatment | −1.375 | 0.642 | 0.032 |